ProTime self-management yielding improvement of fluency and quality of life

Thrombosis and Haemostasis

Volumn 98, Issue 4, 2007, Pages 889-895

  Völler, Heinz ^a   Taborski, Uwe ^b   Dovifat, Clemens ^a   Hartwig, Ines ^c   Kadar, Janos G ^d   Wegscheider, Karl ^e   Zucker, Marcia L ^f,i   LaDuca, Frank M ^g   Ansell, Jack ^h  

^a Klinik am See   (Germany)

^b Gesellschaft für Humanplasma   (Germany)

^c MtBASA   (Germany)

^d Outpatient Clinic for Coagulation Disorders Köln West   (Germany)

^e UNIVERSITY OF HAMBURG   (Germany)

^f Response Biomedical Corp   (Canada)

^g International Technidyne Corporation   (United States)

^h BOSTON UNIVERSITY MEDICAL CENTER   (United States)

ⁱ NONE   (Canada)

Author keywords

INR; Oral anticoagulation; Quality of life; Self management

Indexed keywords

ANTIVITAMIN K;

ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; GERMANY; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEART ATRIUM FIBRILLATION; HEART VALVE REPLACEMENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; KNOWLEDGE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT SATISFACTION; PHYSICAL CAPACITY; POINT OF CARE TESTING; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SELF CARE; SELF EVALUATION; SYSTEMATIC ERROR; THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; FEMALE; GERMANY; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PATIENT SATISFACTION; PROTHROMBIN TIME; QUALITY OF LIFE; QUESTIONNAIRES; SELF CARE; VITAMIN K;

EID: 35048859202     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-02-0143     Document Type: Article

References (24)

1. Fuster V, Ryden LE, Asinger RW, et al.; American College of Cardiology/ American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation); North American Society of Pacing and Electrophysiology. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation 2001; 104: 2118-2150.
2. Kearon C, Ginsberg JS, Kovacs MJ, et al.; Extended Low-Intensity Anticoagulation for Thrombo-Embolism Investigators. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 2003; 349: 631-639.
3. Salem DN, Stein PD, Al-Ahmad A, et al. Anti-thrombotic therapy in valvular heart disease-native and prosthetic: the Seventh ACCP Conference on Anti-thrombotic and Thrombolytic Therapy. Chest 2004; 126 (3 Suppl): 457S-482S.
4. Cannegieter SC, Rosendaal FR, Wintzen AR, et al. Optimal oral anticoagulant therapy in patients with mechanical haeart valves. N Engl J Med 1995; 333: 11-17.
5. Ansell J, Hirsh J, Poller L, et al. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3 Suppl): 204S-233S.
6. Samsa GP, Matchar DB. Relationship between test frequency and outcomes of anticoagulation: A literature review and commentary with implications for the design of randomized trails of patient self-management. J Thromb Thrombolysis 2000; 9: 283-292.
7. Sawicki PT. A structured teaching and self-management program for patients receiving oral anticoagulation: A randomized controlled trial. J Am Med Assoc 1999; 281:145-150.
8. Völler H, Dovifat C, Glatz J, et al. Self management of oral anticoagulation with the IN Ratio system: impact of a structured teaching program on patient's knowledge of medical background and procedures. Eur J Cardiovasc Prev Rehabil 2004; 11: 442-447.
9. Völler H, Dovifat C, Wegscheider K. Experience with INR-self-management: Patient selection and complication rates. Z Kardiol 2005; 94: 801-807.
10. Oral Anticoagulation Monitoring Study Group. Point-of-care prothrombin time measurement for professional and patient self-testing use. A multicenter clinical experience. Oral Anticoagulation Monitoring Study Group. Am J Clin Pathol 2001; 115: 288-296.
11. Bernardo A, Völler H. Guidelines for patient self-management of oral anticoagulation. Dtsch Med Wschr 2001; 126: 346-351.
12. Rosendaal FR, Cannegieter SC, van der Meer FJM, et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993; 69: 236-239.
13. Christensen TD, Andersen NT, Atterman J, et al. Mechanical heart valve patients can manage oral anti-coagulant therapy themselves. Eur J Cardio Thorac Surg 2003; 23: 292-298.
14. Cromheecke ME, Levy M, Colly LP, et. al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet 2000; 356: 97-102.
15. Koertke H, Korfer R. International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous? Ann Thorac Surg 2001; 71: 44-48.
16. Sunderji R, Gin K, Shalansky K, et al. A randomized trial of patients self-managed versus physician-managed oral anticoagulation. Can J Cardiol 2004; 20: 1117-1123.
17. Siebenhofer A, Berghold A, Sawicki PT. Systematic review of studies of self-management of oral anti-coagulation. Thromb Haemost 2004; 91: 225-232.
18. Siebenhofer A, Rakovac I, Kleespies C, et al. Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial, Thromb Haemost 2007; 97: 408-416.
19. Perry SL, Samsa GP, Ortel TL. Point-of-care testing of the international normalized ratio in patients with antiphospholipid antibodies. Thromb Haemost 2005; 94: 1196-1202.
20. Braun S, Watzke H, Hasenkam JM, et al. Performance evaluation of the new CoaguChek XS system compared with the established CoaguChek system by patients experienced in INR-self management. Thromb Haemost 2007; 97: 310-314
21. Mörsdorf S, Erdlenbruch W, Taborski U, et al. Training of patients for self-management of oral anti-coagulant therapy: Standards, patients suitability and clinical aspects. Semin Thromb Hemost 1999; 25: 109-115.
22. Kulinna W, Ney D, Wenzel T, et al. The effect of self-monitoring the INR on quality of anticoagulation and quality of life. Semin Thromb Hemost 1999; 25: 123-126.
23. Heneghan C, Alonso-Coello P, Garcia-Alamino JM, et al. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 2006; 367: 404-411.
24. Menendez-Jandula B, Souto JC, Oliver A, et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Ann Intern Med 2005; 142: 1-10.